Magellan Bioscience Group logo

Magellan Bioscience Group

North America, Florida, United States, Tampa

Description

Magellan BioScience Group identifies lead candidates derived from microorganisms for the development of new chemical entities.

Investor Profile

Magellan Bioscience Group has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Developer Platform
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Magellan Bioscience Group frequently co-invest with?

BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Advent-Morro Equity Partners
Asia, Manila, Philippines, San Juan
Co-Investments: 1

What are some of recent deals done by Magellan Bioscience Group?

Bioheart

Sunrise, Florida, United States

Bioheart is a biotech company that focuses on the development of effective cell technologies to treat cardiovascular diseases.

BiotechnologyDeveloper PlatformHealth CareTherapeutics
Series UnknownSep 27, 2005
Amount Raised: $15,000,000